Big announcement

1. China Telecom's net profit for 2023 was 30.45 billion yuan, up 10.3% year-on-year

$CHINA TELECOM (00728.HK)$The 2023 Annual Results Report was announced. According to Chinese accounting standards, total operating revenue was RMB 507.843 billion (same below), an increase of 6.9% year-on-year. Net profit attributable to shareholders was RMB 30.446 billion, an increase of 10.3%, and earnings per share were 33 points. In 2023, the company will actively fulfill its promise that “within three years after the issuance and listing of A-shares, profits distributed in cash every year will gradually increase to more than 70% of the profit shareholders should account for that year”.

2. China Unicom's net profit is expected to increase by 11.8% to RMB 18.7 billion for the whole year

$CHINA UNICOM (00762.HK)$Preliminary financial data for 2023 was released. Operating revenue is estimated to be about 372.6 billion yuan (same below), an increase of about 5% year-on-year, of which service revenue is 335.2 billion yuan, an increase of 5%, achieving steady growth. Net profit for the year is estimated to be about 18.7 billion yuan, an increase of 11.8%, achieving double-digit growth for seven consecutive years. In the next step, the company will actively grasp short-, medium-, and long-term development relationships, and return more vigorously to shareholders on the basis of saving momentum for long-term steady growth.

3. Haidilao will start implementing the Haidilao Restaurant franchise model

$HAIDILAO (06862.HK)$Announced, the company is pleased to announce that it will begin implementing the Haidilao Restaurant franchise model to further promote the expansion of the restaurant network through diversified business models. The company believes that introducing a franchise model will enhance operating capabilities, introduce more high-quality resources, improve operational efficiency, help the Haidilao brand expand to more regions, and provide services to a wider range of customers on the basis of continuing to guarantee management standards and customer experience.

4. Country Garden: Will consider applying for an approval order from the High Court in line with the progress of overseas restructuring

$COUNTRY GARDEN (02007.HK)$Further announcements will be issued regarding the winding-up petition. The company will consider whether to apply for an approval order from the Hong Kong High Court at a later stage, taking into account the progress of its overseas restructuring. The company will notify its shareholders and investors of relevant decisions and make further announcements in due course.

Earnings Report

$CHINA TELECOM (00728.HK)$2023 net profit of RMB 30.446 billion increased 10.3% year-on-year

$CHINA UNICOM (00762.HK)$Net profit is expected to increase by 11.8% to RMB 18.7 billion for the whole year

$CHINA RE (01508.HK)$Expected net profit of 5.2 billion yuan to 6.2 billion yuan in 2023

$HENLIUS (02696.HK)$Yingxi: It is estimated that the annual loss will be turned into a profit of more than 500 million yuan

$ASIA CEMENT CH (00743.HK)$Annual revenue decreased by about 23% to $7.427 billion with a final interest rate of 4.1 percent

$SIPAI HEALTH (00314.HK)$: It is estimated that adjusted losses during the year and losses during the year may narrow by more than 40% and 80% respectively

Operational data

$COUNTRY GARDEN (02007.HK)$The sales amount of the February shareholders' equity contract was about 3.72 billion yuan

$AGILE GROUP (03383.HK)$The total amount of pre-sales in February was 1.54 billion yuan

$MIDEA REAL EST (03990.HK)$The contract sales amount for the first 2 months was about 6.17 billion yuan

$ZHENRO PPT (06158.HK)$The February contract sales amount was about 471 million yuan

Investment and operation

$HAIDILAO (06862.HK)$The franchise model for Haidilao Restaurant will be implemented

$SH PHARMA (02607.HK)$: I031 clinical trial application accepted

$LUYE PHARMA (02186.HK)$: The innovative preparation LY01610 has completed the enrollment of the first patients in phase III clinical trials

$CIRC (01763.HK)$: CNNC Headway's novel urea 13C breath test kit obtained a clinical trial approval notice

$CHINA TAIPING (00966.HK)$: Purchase an aircraft with an operating lease arrangement

$DATANG RENEW (01798.HK)$Set up a joint venture to jointly develop a new energy project in Wuchuan County, Zunyi

$CRRC (01766.HK)$From December to March, contracts with a total value of about RMB 34.9 billion were signed

Repurchase cancellation

$HSBC HOLDINGS (00005.HK)$On March 1, it cost HK$183 million to repurchase 2.996 million shares

$AIA (01299.HK)$On March 4, it cost HK$99.78 million to buy back 1,592,400 shares

$STANCHART (02888.HK)$On March 1, it cost £8.44,200 to buy back 1,248,900 shares

$KUAISHOU-W (01024.HK)$On March 4, 717,000 shares were purchased at HK$31.78 million

$LIVZON PHARMA (01513.HK)$: As of February 29, a total of 2,476,300 H shares have been repurchased

$SWIRE PACIFIC A (00019.HK)$On March 4, 282,000 shares were purchased at HK$17.45 million

edit/new